Discover
Stocks
Consumer Goods
ATRA
ATRA
Atara Biotherapeutics Inc
1.49
0.01
(
0.68%
)
Market Open
Delayed Prices By NASDAQ,
in USD
Trade
Buy
ATRA
Atara Biotherapeutics Inc
Overview
Chart
Analysis
News
Stats
Trade
Buy
FINANCIAL SUMMARY
For the fiscal year ended 31/12/2022: Atara Biotherapeutics Inc's revenues increased by 212.55% and amounted to 63.57M. Net income increased by 32.88% to -228.30M. Net assets decreased by 54.71% to 126.64M and EPS increased from -3.63 to -2.24.
ATRA's Investor Relations
Income Statement
Balance Sheet
Cash Flow Statement
Quarterly
Gross Margin
-185.02%
Net Profit Margin
-406.28%
Operating Margin
-4,551.42%
Return On Investment
-92.59%